Research at Oslo University Hospital

One branch of the Marie-Curie program, called “EU – Glia PhD” is a Europe wide consortium represented by internationally respected neuroscientists, industry and partner organizations.  Within this several million Euros grand program financing PhD students, Oslo is represented via Kjell Heuser and Toni Berger, who have met together with the "EU Glia-PhD" consortium at the College de France to discuss recent progresses of their research.

Researchers at Department for Microbiology, Department for Medical Biochemistry and Department for Newborn Screening have used single-molecule fluorescence microscopy to track single protein molecules as they move along a linear piece of DNA held in place by the use of a laser/optical tweezers. By tracking single protein molecules as they moved along the DNA molecule, the interaction between protein and DNA could be investigated in detail in real-time. This study has been performed by PhD student Arash Ahmadi and co-workers in the group of Bjørn Dalhus at the Department for Microbiology, OUS, and Department for Medical Biochemistry, UiO. The study is part of a collaboration between OUS, UiO, NTNU and the University of Bielefeld, Germany.

Fredrik Schjesvold, head of the Oslo Myeloma Center at Oslo University Hospital, receives 20 mill NOK from The national programme for clinical therapy research - KLINBEFORSK.
The supported project is entitled "The REMNANT study – Does early treatment of relapse increase survival in myeloma?" 
This is one of four projects coordinated from OUH receiving funding from KLINBEFORSK in 2018. The other three are headed by Michael Bretthauer, Guro Elisabeth Lind and Øyvind Molberg.

Senior scientist Helga B. Landsverk and her co-workers in Randi G. Syljuåsens group have identified new factors in signaling from the transcription machinery to the DNA damage kinase ATR (Ataxia Telangiectasia andRad3-related). The results are published in the prestigious journal Nucleic Acids Research.

The board of the South-Eastern Norway Regional Health Authority (Helse Sør-Øst) has distributed financial resources to new research projects for 2019. Of the in total 620 incoming applications 109 new projects were granted support.
A substantial amount of the resources goes to young researchers. Support is given to a number og doctoral and post doctoral stipendiates, as well as to researcher grants and career grants. The latter category is for young outstanding researchers planning to establish an independent research group.

In order to stimulate excellent research and draw attention to the hospital's extensive research activity, Oslo University Hospital reward outstanding publications regularly. 

Six research groups were awarded for their excellent papers published during the first half-year of 2018 on December 7th in the large auditorium at Ullevål sykehus. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.

Harald Stenmark, head of the Cellular Membrane Dynamics group at the Department of Molecular Biology and the Center for Cancer Cell Reprogramming is the leader of one of 25 research projects receiving in total 100 million NOK from the Research Council of Norway and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (Diku), who together run the program INTPART. The aim is to strengthen collaborations with Brazil, Canada, India, Japan, China, Russia, South Africa and USA.
The project led by Stenmark now receiving support is the Chinese-Norwegian Partnership for Education and Research in Cancer Cell Biology (ChiNoCell).